Tremendous-resolution microscopy reveals nanoscale structure of antibody-receptor interactions

A brand new examine reveals how the single-molecule group of receptors in a mobile context determines the operate of antibodies, opening up new pathways for the event of most cancers immunotherapies.

Therapeutic antibodies have reworked most cancers remedy, but the precise molecular mechanisms that drive their therapeutic results have remained elusive. A staff led by Ralf Jungmann (Chair Professor for Molecular Physics of Life at LMU and chief of the Molecular Imaging and Bionanotechnology analysis group on the Max Planck Institute of Biochemistry) has now taken an unprecedented have a look at how therapeutic antibodies reshape receptor group on the single-molecule stage, and the way this impacts the operate of the antibodies.

Utilizing Decision Enhancement by Sequential Imaging (RESI)—a novel super-resolution microscopy approach able to visualizing single proteins—the researchers immediately imaged the nanoscale structure of CD20 receptors and their interactions with broadly used anti-CD20 antibodies equivalent to Rituximab and Obinutuzumab.

“For the primary time, we are able to visualize in intact cells how antibody-receptor complexes manage on the single-protein stage,” explains Jungmann, senior writer of the examine, which was printed just lately within the journal Nature Communications. “These nanoscale patterns immediately correlate with therapeutic operate and supply a blueprint for rational antibody design.”

Visualizing antibody-receptor complexes at single-protein decision

Therapeutic monoclonal antibodies act by way of a number of mechanisms—triggering immune cells, activating complement pathways, or immediately inducing cell demise. These results depend upon how antibodies bind and reorganize receptors on the cell floor. Nonetheless, conventional imaging strategies lacked the decision to disclose these preparations of their native mobile context.

The Jungmann staff overcame this barrier by implementing multi-target 3D RESI imaging, a way that labels receptors and antibodies with orthogonal DNA barcodes and sequentially visualizes them at sub-nanometer precision. This allowed the staff to resolve the group of CD20 receptors and their sure antibodies immediately on the cell membrane.

“We are able to now immediately see how structural modifications in antibody design translate into totally different receptor patterns and mobile responses,” says Isabelle Pachmayr, first writer of the examine. “This opens the door to structure-guided improvement of next-generation monoclonal antibodies.”

A brand new period for antibody analysis

Past CD20, this RESI expertise is able to investigating nearly any membrane receptor and therapeutic antibody with molecular decision immediately at intact cells. As a result of RESI visualizes entire cells with excessive throughput, it allows systematic evaluation of antibody candidates at a decision beforehand solely accessible by way of cryo-EM, however now immediately within the mobile setting and with distinctive molecular specificity.

Trying forward, the staff envisions combining RESI with the imaging of a number of receptors and intracellular signaling molecules to map complete therapeutic pathways. “For the primary time, RESI combines the construction of nanoscale receptors with their operate in a mobile context,” summarizes Jungmann. “This expertise has the potential to basically remodel immunotherapies.”